ArticleAlimentary pharmacology & therapeutics2021

The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme.

Francis A Farraye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.